European Medicines Agency (European Equivalent Of FDA) Says Gilead's Remdesivir Shown To Be Active Against COVID-19, 2 SARS-, MERS-Coronavirus Infections, But Notes 'Currently Only Limited Data On Use' in COVID-19 Patients